Anderson School of Management, University of California, Los Angeles 110 Westwood Plaza, Suite A-405 Los Angeles, CA 90095-1481, United States.
The Wharton School, University of Pennsylvania, 3620 Locust Walk, Philadelphia, PA 19104, USA.
Prev Med. 2017 Oct;103:98-102. doi: 10.1016/j.ypmed.2017.07.019. Epub 2017 Jul 24.
Expanding on evidence that interventions to improve health are more effective when informed by behavioral science, we explore whether reminders designed to harness behavioral science principles can improve medication adherence. We conducted a randomized controlled trial with 46,581 U.S. participants with commercial or Medicare Advantage insurance from Humana. Participants were randomly assigned to one of four experimental conditions. Participants in the usual care condition only received standard mailings that the insurer usually sends. In addition to the standard mailings, participants in the other three conditions also received (1) mailings that reminded them to take a target medication (basic reminder condition), (2) reminders that prompted them to predict their medication adherence in the next 30days (prediction condition), or (3) reminders that prompted them to commit to a self-determined level of adherence for the next 30days (commitment condition). We sent these mailings once a month for three months from November, 2014 through January, 2015, and tracked prescription refills. We find that, during the mailing period, reminders increased adherence by 0.95 percentage points (p<0.05), and this effect was driven by the prediction and commitment conditions; during the three-month post-mailing period, reminders increased adherence by 0.98 percentage points (p<0.05), and this effect was driven by the basic reminder and commitment conditions. The reminders increased medication adherence by 0.7 pills per dollar spent over our 181day study period. Trial registry name: Effect of Reminders on Adherence. Registration identification number: NCT02411006 URL for the registry: https://clinicaltrials.gov/ct2/show/NCT02411006.
基于干预措施在行为科学的指导下更有效的证据,我们探讨了旨在利用行为科学原理的提醒是否可以提高药物依从性。我们对来自Humana 的 46581 名有商业或联邦医疗保险优势保险的美国参与者进行了一项随机对照试验。参与者被随机分配到四个实验组中的一个。常规护理组的参与者只收到了保险公司通常发送的标准邮件。除了标准邮件外,其他三个组的参与者还收到了(1)提醒他们服用目标药物的邮件(基本提醒条件),(2)提示他们预测未来 30 天药物依从性的提醒(预测条件),或(3)提示他们承诺在未来 30 天内达到自我确定的依从性水平的提醒(承诺条件)。我们从 2014 年 11 月至 2015 年 1 月每月发送一次邮件,持续三个月,并跟踪处方续配情况。我们发现,在邮件发送期间,提醒增加了 0.95 个百分点的依从率(p<0.05),这种效果是由预测和承诺条件驱动的;在邮件发送后的三个月内,提醒增加了 0.98 个百分点的依从率(p<0.05),这种效果是由基本提醒和承诺条件驱动的。在我们 181 天的研究期间,每花费一美元,药物的依从性就会增加 0.7 片。试验登记名称:提醒对依从性的影响。登记识别号码:NCT02411006。登记网址:https://clinicaltrials.gov/ct2/show/NCT02411006。